Novartis Inflammasome Research, Inc.

États‑Unis d’Amérique

Commandez votre montre hebdomadaire Novartis Inflammasome Research, Inc.
Quantité totale PI 10
Rang # Quantité totale PI 157 866
Note d'activité PI 0/5.0    0
Rang # Activité PI 1 715 794

Brevets

Marques

0 0
0 0
10 0
0
 
Dernier brevet 2021 - Gut-targeted nlrp3 antagonists a...
Premier brevet 2019 - Methods of treating or selecting...

Derniers inventions, produits et services

2020 Invention Compounds and compositions for treating conditions associated with nlrp activity. In one aspect, ...
Invention Gut-targeted nlrp3 antagonists and their use in therapy. Provided herein are gut-targeted NLRP3 a...
2019 Invention The compounds and compositions for treating conditions associated with nlrp activity. In one aspe...
Invention Methods of treating or selecting a treatment for a subject resistant to tnf inhibitor using a nlr...
Invention Nlrp modulators. In one aspect, compounds of Formula AA, or a pharmaceutically acceptable salt th...